Powering precision medicine with insights from a global oncology network

Syapse partners with health systems and life sciences companies to deliver clinical, programmatic, and research insights from the world’s largest network of health systems focused on precision medicine

Advocate Aurora Health

launched a precision medicine program that will bring new treatment options to cancer patients.

Swedish Cancer Institute

is scaling precision medicine and clinical trials in the community.

Henry Ford Cancer Institute

uses real-world evidence to improve cancer care in Michigan.

Our partners in precision medicine

In the news

South Korea’s SNUH extends partnership with Syapse to expand access to precision medicine

8/9/19 - Syapse, a company accelerating precision medicine through insights derived from its global health system network, and Seoul National University Hospital (SNUH) in South Korea announced that they have extended their partnership with a new multi-year agreement. As part of their partnership, SNUH and Syapse will collaboratively work towards building South Koreaâs first real-world data sharing network for leading precision oncology hospitals in the region.

Read

Blog

Precision Medicine Goes Mainstream at Leading Health Systems

Precision medicine (or personalized medicine) has been a buzzword in the healthcare industry for many years. Depending on the audience, its…

Read

Let’s talk

If you’d like to learn more about Syapse, tell us a little about yourself and we will reach out as soon as possible.